You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

REGO

Cancer Type: Gastrointestinal, Gastrointestinal Stromal Tumours, Sarcoma, GIST      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
Exceptional Access Program
    regorafenib - For the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST), according to specific criteria.

You might also be interested in